P01.005 The impact of thrombocytopenia from concomitant and adjuvant temozolomide in patients with glioblastoma

BACKGROUND: Temozolomide (TMZ) administered daily with radiation therapy for six weeks, followed by adjuvant TMZ for six months is standard therapy for patients (pts) with newly diagnosed glioblastoma (GBM). Thrombocytopenia (TBP) usually appears in 10 % of patients and is responsible for treatment...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Nivet, A, Schernberg, A, Louvel, G, Dumont, S, Ammary, S, Rehalia-Blanchard, A, Clavère, P, Parker, F, Pallud, J, Dhermain, F
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Poster Presentations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144430/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.047
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料